google-site-verification: googlec7193c3de77668c9.html

Tag Archives: They

FDA approves quadruplet regimen for adults with newly diagnosed multiple myeloma

[ The U.S. Food and Drug Administration has approved Darzalex Faspro (daratumumab and hyaluronidase-fihj) in combination with bortezomib, lenalidomide, and dexamethasone (D-VRd) for the treatment of adult patients with newly diagnosed multiple myeloma (MM) who are ineligible for autologous stem cell transplant (ASCT). D-VRd is the only anti-CD38 antibody-based regimen …

Read More »

Recent Comments

    You have been rate limited for making too many requests in a short time frame.